Baseline splenic volume as a surrogate marker of FOLFIRINOX efficacy in advanced pancreatic carcinoma

BACKGROUND: The FOLFIRINOX regimen is the standard first-line treatment for advanced pancreatic adenocarcinoma (aPDAC). However, because of its potential toxicity, predictive biomarkers could help clinical decision-making. METHODS: A cohort of 97 aPDAC patients treated with first-line FOLFIRINOX wer...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Aarnink, Anne, Richard, Corentin, Truntzer, Caroline, Vincent, Julie, Bengrine, Leila, Vienot, Angélique, Borg, Christophe, Ghiringhelli, Francois
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5986639/
https://ncbi.nlm.nih.gov/pubmed/29876012
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25424
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados